| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 73.866 | 10.846 | 9.899 | 19.460 | 27.326 | 54.842 |
| Total Income - EUR | - | - | - | 0 | 73.878 | 10.846 | 9.899 | 19.460 | 27.326 | 54.851 |
| Total Expenses - EUR | - | - | - | 1.854 | 77.552 | 9.516 | 6.537 | 5.032 | 15.608 | 21.210 |
| Gross Profit/Loss - EUR | - | - | - | -1.854 | -3.674 | 1.331 | 3.362 | 14.428 | 11.718 | 33.641 |
| Net Profit/Loss - EUR | - | - | - | -1.854 | -5.577 | 1.028 | 3.065 | 14.113 | 11.486 | 28.856 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Derzelas Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 122 | 120 | 0 | 0 | 0 | 0 | 37.009 |
| Current Assets | - | - | - | 146 | 17.261 | 7.096 | 5.976 | 20.405 | 14.328 | 48.890 |
| Inventories | - | - | - | 0 | 7.564 | 5.207 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 4.298 | 298 | 1.298 | 10.857 | 546 | 23.161 |
| Cash | - | - | - | 146 | 5.399 | 1.591 | 4.678 | 9.549 | 13.782 | 25.729 |
| Shareholders Funds | - | - | - | -1.811 | -7.353 | -6.185 | -2.983 | 11.121 | 12.618 | 28.939 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 2.080 | 24.734 | 13.282 | 8.959 | 9.285 | 1.710 | 56.960 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Derzelas Med S.r.l.